Written by The Business Journal Staff
California Health Sciences University in Clovis is one step closer to accreditation for its Doctor of Pharmacy program.
The Accreditation Council for Pharmacy Education (ACPE) recently moved the university from “pre-candidate” status to “candidate” status, the second phase of a three-step process toward full accreditation. ACPE is the national agency that accredits all Doctor of Pharmacy programs.
“We’re proud to achieve this critical milestone with ACPE, which grants our students the same rights as full accreditation allowing them to take the pharmacy board exams upon graduation,” said Florence Dunn, the founding president at CHSU, in a statement. “With the leadership and guidance from Dr. Wendy Duncun, Provost and Interim Dean of Pharmacy and her amazing team of administrators and faculty, we are providing our students with an excellent pharmacy education. This achievement also gives incoming students the reassurance they need to select our new, innovative pharmacy program right here in the Valley.”
CHSU initiated the accreditation process with the ACPE shortly after the university was founded in 2012. ACPE granted the CHSU College of Pharmacy pre-candidate accreditation in January 2014, allowing CHSU to welcome its first class of pharmacy students in August 2014.
Provost and Interim Dean of Pharmacy Wendy Duncun is very familiar with the accreditation process. In her role as a site evaluator for the American Council for Pharmaceutical Education, Duncun successfully completed self-studies resulting in accreditation and reaccreditation at four institutions at both the programmatic and regional level.
“We are creating a culture of student success at CHSU through our lifelong learning and leadership development programs to enable students, especially those from underserved communities in our region, to be successful in our program and have a great career as a pharmacist,” Duncun said in a statement. “We are preparing our graduates to perform at the top of the licenses through team-based learning and an innovative curriculum that includes physical assessment and delivery of primary health care services to meet the demand for health professionals in this region.”
The university and the Doctor of Pharmacy program will be eligible for full accreditation by WSCUC and ACPE upon graduation of the first class in 2018.
— Business Journal staff
Regulators sign off on Aetna-Humana merger
California’s managed-care regulator has approved Aetna Inc.’s $37 billion acquisition of Humana Inc., despite her past criticism of Aetna’s repeated rate hikes for employers.
California officials don’t have the authority on their own to block the national insurance merger, but their decisions can be influential as the companies try to win antitrust approval from the U.S. Department of Justice.
Shelley Rouillard, director of the state Department of Managed Health Care, said she reached an agreement with Aetna that should help keep future rate increases to a minimum and improve the quality of patient care.
Aetna also agreed to spend nearly $50 million toward the expansion of a Fresno service center and for a variety of health-related initiatives in the state.
California’s other insurance regulator, Insurance Commissioner Dave Jones, rejected Anthem Inc.’s $54 billion acquisition of Cigna Corp. and asked the Justice Department to stop the deal as anti-competitive.
Industry analysts have grown more pessimistic about the Anthem-Cigna deal clearing regulatory scrutiny in Washington, D.C., due to antitrust concerns and internal management conflicts. But they remain more upbeat about the prospects for Aetna’s transaction.
Rouillard said she’s still reviewing the Anthem-Cigna merger but didn’t give any timing for her decision.
“There are elements that are similar across mergers, but each one also has unique characteristics,” she said.
Aetna called Rouillard’s announcement the “latest positive step” for the Humana merger and said it expects the transaction to close in the second half of this year.
“We are committed to making strategic investments to address deficiencies in the health care delivery system, make health care more cost effective, and improve the health and wellbeing of Aetna members and their beneficiaries throughout the state,” said Aetna spokeswoman Anjie Coplin.
One of the biggest sticking points for California officials in considering the Aetna proposal was a string of rate hikes for small businesses in recent years.
The managed-care agency had deemed four of Aetna’s premium increases unreasonable since 2013, but the company went ahead with each one. California officials review premiums but have no authority to stop health insurance rate increases.
Last year, Rouillard accused Aetna of “price gouging” after it raised rates on small employers by 21 percent. Consumer advocates have said they fear problems over rate increases and affordability will get worse as insurers consolidate market power.
In an 18-page agreement with the managed-care department, Aetna said it “will commit to keeping HMO small group premium rate increases to a minimum.”
But the agreement doesn’t bar Aetna from going ahead with a rate hike deemed unreasonable by the agency.
However, if the company were to move ahead on such a proposal, under the accommodation reached with Rouillard, Aetna would hold off on further rate increases for a short period. Aetna also would file proposed rates 90 days in advance of their effective date, up from 60 days under current rules.
Rouillard said those conditions offer an incentive for the company to negotiate further with her office.
“It forces them to come to the table and work something out that’s reasonable,” Rouillard said.
Aetna hasn’t sold individual policies on the Covered California insurance exchange, and the company told regulators it has no plans to do so. Humana also doesn’t sell policies on the California exchange.
Ana Gupte, a health-care analyst at the investment bank Leerink Partners, said Rouillard’s decision is “another indication that the merger antitrust review is on track” for Aetna, particularly in light of more pushback against Anthem.
At a hearing in January with the managed-care agency, Aetna executives said that the company’s combination with Humana should yield $1.25 billion in savings by 2018 and even more in subsequent years.
But some consumer groups and health-policy experts have questioned whether much of those savings will be passed along to policyholders.
In her review, Rouillard also criticized Aetna for poor marks on patient care. In the agreement, Aetna pledged to improve its scores on care for hypertension, diabetes, stroke and prevention of heart attacks by the end of 2018.
Aetna also agreed to spend $49.5 million toward community investment, including:
$23 million over two years for expansion of its Fresno service center and to help cover health benefits for lower-income workers.
$16.5 million to support accountable-care organizations and pay-for-performance programs in California.
$6 million over three years to nonprofit organizations providing consumer assistance to seniors, persons with disabilities and patients who are eligible for both Medicare and Medicaid.
$3 million over three years to the California Dental Association Foundation to support dental services for low-income and underserved communities.
$1 million for telehealth services to increase access for mental health care and to reduce unnecessary emergency room visits.
— Chad Terhune, Kaiser Health News
Wells Fargo first major donor for cancer center
Community Medical Centers recently celebrated its first gift of $75,000 to benefit a regional cancer treatment and research center to be built at Clovis Community Hospital.
Design work for the $65 million center began in May, with a projected opening date in 2018.
As the project’s first major donor, Wells Fargo officials said the gift is meant to benefit the community as a whole.
“There are many people that depend on Community Medical Centers, and our hope by providing support to Community Medical Centers, along with all other great institutions, is that we will be able to continue these great services for our families, friends and loved ones,” said Sandy Raco, Wells Fargo Central Valley market president, in a video.
The facility will be the only comprehensive cancer center of its kind in the San Joaquin Valley.
— Business Journal staff